| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CEO | Chief Executive Officer
1 company
Evans John M. is a CEO at Beam Therapeutics Inc.. Recent SEC Form 4 filings include 0 buys and 20 sells.
Estimated insider holdings value: $31.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 2, 2025 | BEAM Beam Therapeutics Inc. | CEO | Sale+OE | 50,000 | $24.57 | $1,228,322.50 | -2.5% | +8.3% | - | |
| Apr 1, 2025 | BEAM Beam Therapeutics Inc. | CEO | Sell | 30,663 | $18.35 | $562,684.45 | -3.0% | -3.5% | +37.3% | |
| Jan 30, 2025 | BEAM Beam Therapeutics Inc. | CEO | Sell | 30,000 | $26.75 | $802,483.82 | -1.6% | -26.9% | +1.2% | |
| Sep 30, 2024 | BEAM Beam Therapeutics Inc. | CEO | Sell | 60,000 | $24.60 | $1,476,024.00 | -6.0% | +3.1% | -0.9% | |
| Jun 27, 2024 | BEAM Beam Therapeutics Inc. | CEO | Sell | 60,000 | $24.50 | $1,470,156.00 | -5.7% | +2.2% | -29.9% | |
| Apr 1, 2024 | BEAM Beam Therapeutics Inc. | CEO | Sell | 18,102 | $32.13 | $581,617.26 | -1.7% | -29.4% | -46.0% | |
| Mar 28, 2024 | BEAM Beam Therapeutics Inc. | CEO | Sell | 60,000 | $33.86 | $2,031,402.00 | -5.7% | -24.8% | -32.8% | |
| Jan 31, 2024 | BEAM Beam Therapeutics Inc. | CEO | Sell | 60,000 | $25.33 | $1,519,800.00 | -5.4% | -13.0% | +11.8% | |
| Apr 4, 2023 | BEAM Beam Therapeutics Inc. | CEO | Sell | 11,654 | $29.63 | $345,334.01 | -0.5% | +8.0% | +0.4% | |
| Oct 31, 2022 | BEAM Beam Therapeutics Inc. | CEO | Sell | 50,000 | $46.33 | $2,316,428.33 | -1.0% | -4.4% | -52.0% |